Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

750 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer.
Stares M, Ding TE, Stratton C, Thomson F, Baxter M, Cagney H, Cumming K, Swan A, Ross F, Barrie C, Maclennan K, Campbell S, Evans T, Tufail A, Harrow S, Lord H, Laird B, MacKean M, Phillips I. Stares M, et al. Among authors: phillips i. ESMO Open. 2022 Apr;7(2):100445. doi: 10.1016/j.esmoop.2022.100445. Epub 2022 Apr 7. ESMO Open. 2022. PMID: 35398717 Free PMC article.
Clinical impact of cachexia biomarkers in advanced cancer.
Phillips I, Stares M. Phillips I, et al. Ann Palliat Med. 2023 Mar;12(2):262-264. doi: 10.21037/apm-22-1416. Epub 2023 Feb 1. Ann Palliat Med. 2023. PMID: 36786103 Free article. No abstract available.
Real-World Impact of SABR on Stage I Non-Small-Cell Lung Cancer Outcomes at a Scottish Cancer Centre.
Stares M, Lewis G, Vallet M, Killean A, Tramonti G, Patrizio A, Mackean M, Harrow S, Barrie C, MacLennan K, Campbell S, Evans T, Tufail A, Edinburgh Cancer Informatics Programme, Hall P, Phillips I. Stares M, et al. Among authors: phillips i. Cancers (Basel). 2023 Feb 23;15(5):1431. doi: 10.3390/cancers15051431. Cancers (Basel). 2023. PMID: 36900224 Free PMC article.
Immune-Related Adverse Events, Biomarkers of Systemic Inflammation, and Survival Outcomes in Patients Receiving Pembrolizumab for Non-Small-Cell Lung Cancer.
Raynes G, Stares M, Low S, Haron D, Sarwar H, Abhi D, Barrie C, Laird B, Caledonian Cachexia Collaborative, Phillips I, MacKean M. Raynes G, et al. Among authors: phillips i. Cancers (Basel). 2023 Nov 21;15(23):5502. doi: 10.3390/cancers15235502. Cancers (Basel). 2023. PMID: 38067207 Free PMC article.
Early prehabilitation reduces admissions and time in hospital in patients with newly diagnosed lung cancer.
Phillips I, Deans M, Walton A, Vallet M, Mencnarowksi J, McMillan D, Peacock C, Hall P, O'Brien F, Stares M, Mackean M, Plant T, Grecian R, Allan L, Petrie R, Blues D, Haddad S, Barrie C. Phillips I, et al. BMJ Support Palliat Care. 2024 Apr 17:spcare-2024-004869. doi: 10.1136/spcare-2024-004869. Online ahead of print. BMJ Support Palliat Care. 2024. PMID: 38631891
Body weight and composition endpoints in cancer cachexia clinical trials: Systematic Review 4 of the cachexia endpoints series.
Brown LR, Sousa MS, Yule MS, Baracos VE, McMillan DC, Arends J, Balstad TR, Bye A, Dajani O, Dolan RD, Fallon MT, Greil C, Hjermstad MJ, Jakobsen G, Maddocks M, McDonald J, Ottestad IO, Phillips I, Sayers J, Simpson MR, Vagnildhaug OM, Solheim TS, Laird BJA, Skipworth RJE; ‘Cachexia Endpoint Series Working Group’. Brown LR, et al. Among authors: phillips i. J Cachexia Sarcopenia Muscle. 2024 May 13. doi: 10.1002/jcsm.13478. Online ahead of print. J Cachexia Sarcopenia Muscle. 2024. PMID: 38738581 Free article. Review.
750 results